
Carmofur NEW
Price | $34 | $48 |
Package | 50mg | 100mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2025-07-15 |
Product Details
Product Name: Carmofur | CAS No.: 61422-45-5 |
Purity: 98.59% | Supply Ability: 10g |
Release date: 2025/07/15 |
Product Introduction
Bioactivity
Name | Carmofur |
Description | Carmofur (HCFU) is a highly potent acid ceramidase inhibitor, used in the treatment of breast and colorectal cancer. Carmofur has been known to induce leukoencephalopathy. |
In vitro | Carmofur is one of the masked compounds of 5-FU, which was modified for more potent antineoplastic activity and less toxicity. Carmofur is converted in vivo into 5-FU directly or via intermetabolites, such as 1-(carboxypentylcarbamoyl)-5-fluorouracil and/or 1-(carboxypropylcarbomoyl)-5-fluorouraci. Carmofur and its metabolites gradually accumulate in the brain during continuous administration and are removed very slowly. Carmofur has potent neurotoxicity which can produce severe leucoencephalopathy resembling methotrexate leucoencephalopathy both clinically and on brain CT, together with a cerebellar syndrome similar to that following 5-FU neurotoxicity. [1] |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 40 mg/mL (155.48 mM), Sonication is recommended. H2O : < 1 mg/mL (insoluble or slightly soluble) Ethanol : 10 mg/mL (38.87 mM), Sonication is recommended. |
Keywords | VirusProtease | Virus Protease | SARS-CoV | SARSCoV | SARS coronavirus | RNASynthesis | RNA Synthesis | protease | NucleosideAntimetabolite | Nucleoside Antimetabolite/Analog | Nucleoside Antimetabolite | Mpro | Inhibitor | inhibit | DNASynthesis | DNA/RNA Synthesis | DNA Synthesis | derivative | Carmofur | antineoplastic | Analog | 5-fluorouracil |
Inhibitors Related | Stavudine | 5-Fluorouracil | Adenosine | Phenytoin sodium | Procaine | Rifaximin | Hydroxychloroquine | Guanidine hydrochloride | Methotrexate disodium | L-Lysine | Thymidine | Folic acid |
Related Compound Libraries | Anti-Colorectal Cancer Compound Library | DNA Damage & Repair Compound Library | Bioactive Compound Library | Anti-Viral Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Human Metabolite Library | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$34.00/50mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-07-30 | |
$15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-10 | ||
$1.10/1g |
VIP5Y
|
Dideu Industries Group Limited
|
2021-07-01 | |
$0.00/1KG |
VIP6Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-04-29 | |
$1.00/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2020-01-08 | |
$15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-08 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY